“…4,9,10 In addition, CC flow impairments evaluated using OCTA has been reported in eyes with diseases such as age-related macular degeneration (AMD), diabetic retinopathy, central serous chorioretinopathy, retinitis pigmentosa, idiopathic epiretinal membrane, Vogt-Koyanagi-Harada disease, and Alport syndrome. 5,[11][12][13][14][15][16][17][18][19] However, the extent of CC flow impairments reported from different studies have been difficult to compare because different instruments and algorithms have been used to generate and analyze the CC en face flow images and because the capillaries of the CC are beyond the resolution of commercial OCTA instruments so investigators lack the ground truth evidence that they are truly imaging the CC in vivo based on OCTA images. 8-12, 14-17, 20-25 Different terms have been used to evaluate CC flow and flow impairments such as CC vessel flow density (VFD), vessel density (VD), vessel diameter index (VDI), perfusion density (PD), vessel length density (VLD), flow voids (FVs), grey value (GV), signal voids, percent choriocapillaris area of nonperfusion (PCAN), 8,9,[20][21][22][23][24][25][26] but we prefer to use the term flow deficits (FDs), since these areas represent regions of undetectable CC flow when using a particular instrument and algorithm rather than the absolute absence of physiological CC flow, since flow might be detectable under different circumstances.…”